•  
  •  
 

Bulletin of Chinese Academy of Sciences (Chinese Version)

Keywords

history of biomedical industry,life science innovation system,industrialization of Penicillin,National Institutes of Health

Document Type

Policy & Management Research

Abstract

The modern pharmaceutical industry began with the large-scale production of chemical drugs. With the radical innovation of basic sciences, such as life science, biomedicine has become the focus of the pharmaceutical industry, with broad prospects. Since World War II, the U.S. government, enterprises and scientific community have cultivated the biomedical industry and scientific foundation, created an environment for innovation, established an effective life science innovation system, and gradually become the innovation highland of biomedicine in the world. Building a biomedical innovation highland is an important part of China to become the world science center. China can learn from U.S. experience to construct Chinese biomedical innovation highland via holding patience and confidence, and enhancing the effectiveness of life science innovation system.

First page

294

Last Page

301

Language

Chinese

Publisher

Bulletin of Chinese Academy of Sciences

References

1 巴里·沃思. 十亿美元分子:追寻完美药物(从实验室到华尔街的传奇). 钱鹏展, 译. 上海:上海科技教育出版社, 2018.

Werth B. The Billion-Dollar Molecule:The Quest for the Perfect Drug. Translated by Qian Z P. Shanghai:Shanghai Scientific and Technological Education Publishing House, 2018. (in Chinese)

2 史蒂文·克莱伯. 创新的演化. 林冬阳, 骆名暄, 译. 南昌:江西人民出版社, 2018.

Klepper S. Experimental Capitalism the Nanoeconomics of American High-Tech Industries. Translated by Lin D Y, Luo M X. Nanchang:Jiangxi People's Publishing House, 2018. (in Chinese)

3 谢宇. 美国科学在衰退吗?. 北京:社会科学文献出版社, 2017.

Xie Y. Is American Science Declining?. Beijing:Social Sciences Academic Press, 2017. (in Chinese)

4 萨莉·史密斯·休斯. 基因泰克:生物技术王国的匠心传奇. 孙焕君, 译. 北京:中国人民大学出版社, 2017.

Hughes S S. Genentech:The Legend of Ingenuity in the Kingdom of Biotechnology. Translated by Sun H J. Beijing:China Renmin University Press, 2017. (in Chinese)

5 Kneller R. The importance of new companies for drug discovery:Origins of a decade of new drugs. Nature Reviews Drug Discovery, 2010, 9(11):867-882.

6 Dolgin E. The tangled history of mRNA vaccines. Nature, 2021, 597(7876):318-324.

7 Dychtwald Z. China's new innovation advantage. Harvard Business Review, 2021, 99(3):55-60.

Share

COinS